ProMIS Neurosciences is engaged in applying its technology platform to build a portfolio of antibody therapies, vaccines, and other antibody-based therapies in neurodegenerative diseases and other misfolded protein diseases, which may include Alzheimer's disease, multiple system atrophy, amyotrophic lateral sclerosis, Parkinson's disease, Lewy body dementia, frontotemporal lobar degeneration, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. We show 1 historical shares outstanding datapoints in our PMN shares outstanding history coverage, used to compute PMN market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing PMN market cap history over the course of time is important for investors
interested in comparing PMN's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of PMN versus a peer is one thing; comparing
PMN market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like PMN can fluctuate over the course of history.
With this page we aim to empower investors researching PMN by allowing them to research the PMN market cap history. |
Free PMN Email Alerts:
Video: The Importance of Market Cap
